Literature DB >> 12997844

Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.

E PATERSON, P B KUNKLER, A L WALPOLE.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; NEOPLASMS/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 12997844      PMCID： PMC2015219          DOI： 10.1136/bmj.1.4801.59

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Cytotoxic agents: III, derivatives of ethyleneimine.

Authors:  J A HENDRY; R F HOMER; F L ROSE; A L WALPOLE
Journal:  Br J Pharmacol Chemother       Date:  1951-09

2.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

3.  RETARDATION of tumor growth in mice by oral administration of ethylenimine derivatives.

Authors: 
Journal:  Arch Biochem       Date:  1950-04

4.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962

5.  ACTION of certain ethylenimine (aziridine) derivatives on mouse leukemia.

Authors: 
Journal:  Arch Biochem       Date:  1950-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.